Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants

Details for Australian Patent Application No. 2002361168 (hide)

Owner Cyplasin Biomedical, Ltd.

Inventors Petzelt, Christian

Agent Pizzeys

Pub. Number AU-B-2002361168

PCT Number PCT/EP02/14511

PCT Pub. Number WO2003/057726

Priority 02019914.7 04.09.02 EP; 02000388.5 07.01.02 EP

Filing date 18 December 2002

Wipo publication date 24 July 2003

Acceptance publication date 8 May 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

10 April 2003 Complete Application Filed

  Priority application(s): 02019914.7 04.09.02 EP; 02000388.5 07.01.02 EP

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2002361168

23 August 2007 Assignment before Grant

  Petzelt, Christian The application has been assigned to Cyplasin Biomedical, Ltd. Assignments before Grant, Section 113 2003

8 May 2008 Application Accepted

  Published as AU-B-2002361168

4 September 2008 Standard Patent Sealed

27 May 2010 Assignment Registered

  Cyplasin Biomedical, Ltd. The patent has been assigned to Bioxen Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002361169-Simultaneous riveting system of flat surfaces for riveters

2002361167-VALUABLE DOCUMENT AND METHOD AND DEVICE FOR EXAMINING SAID VALUABLE DOCUMENT